| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |